Asset Management One’s CRISPR Therapeutics CRSP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.75M | Hold |
35,986
| – | – | 0.01% | 710 |
|
2025
Q1 | $1.22M | Hold |
35,986
| – | – | ﹤0.01% | 766 |
|
2024
Q4 | $1.44M | Hold |
35,986
| – | – | ﹤0.01% | 767 |
|
2024
Q3 | $1.69M | Hold |
35,986
| – | – | 0.01% | 762 |
|
2024
Q2 | $1.94M | Buy |
35,986
+8,886
| +33% | +$480K | 0.01% | 734 |
|
2024
Q1 | $1.85M | Hold |
27,100
| – | – | 0.01% | 757 |
|
2023
Q4 | $1.74M | Buy |
+27,100
| New | +$1.74M | 0.01% | 770 |
|
2022
Q2 | – | Sell |
-100
| Closed | -$6K | – | 1043 |
|
2022
Q1 | $6K | Hold |
100
| – | – | ﹤0.01% | 1035 |
|
2021
Q4 | $7K | Hold |
100
| – | – | ﹤0.01% | 1044 |
|
2021
Q3 | $11K | Sell |
100
-200
| -67% | -$22K | ﹤0.01% | 1037 |
|
2021
Q2 | $48K | Sell |
300
-3,910
| -93% | -$626K | ﹤0.01% | 1028 |
|
2021
Q1 | $512K | Sell |
4,210
-6,922
| -62% | -$842K | ﹤0.01% | 916 |
|
2020
Q4 | $1.76M | Hold |
11,132
| – | – | 0.01% | 800 |
|
2020
Q3 | $931K | Buy |
+11,132
| New | +$931K | ﹤0.01% | 841 |
|